Context Therapeutics Inc. Common Stock

CNTX XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

220M

Short interest (May 15)

1.0%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.86%

↑ 88.8%

Available Shares

↓ 15.5%

Price Chart

Company Overview

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001842952

Asset Type: CS

Market Data

Market Cap: $222,347,608

Employees: 15

Status: Active

Short Interest

Current Borrow Fee 0.86%

Range: 0.74% - 0.86%

Available Shares 1M

Range: 850K - 1.3M

Recent Changes

Fee Change: ↑ 61.5%

Available Change: ↓ 10.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime